Yohei Kirino Selected Research

Disease Progression

1/2022	Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
2/2003	[A solitary lung lesion in Wegener's granulomatosis, which was difficult to differentiate from lung neoplasm].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yohei Kirino Research Topics

Disease

9	VEXAS syndrome 02/2024 - 11/2021
9	Neoplasms (Cancer) 04/2023 - 01/2012
9	Inflammation (Inflammations) 03/2023 - 04/2006
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 08/2017
7	Rheumatoid Arthritis 11/2019 - 04/2006
6	MELAS Syndrome (Syndrome, MELAS) 07/2008 - 10/2004
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 10/2004
4	Behcet Syndrome (Behcet's Syndrome) 01/2024 - 05/2013
4	Adult-Onset Still's Disease 12/2023 - 01/2005
4	Arthritis (Polyarthritis) 07/2023 - 01/2022
4	Infections 01/2023 - 09/2020
4	Ulcer 10/2022 - 06/2010
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 01/2022
3	Familial Mediterranean Fever (Periodic Disease) 09/2022 - 05/2013
3	Relapsing Polychondritis 01/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 12/2019 - 07/2015
2	Tuberculosis (Tuberculoses) 03/2024 - 03/2009
2	Macrophage Activation Syndrome 12/2023 - 07/2023
2	Anemia 10/2023 - 04/2023
2	Fever (Fevers) 07/2023 - 01/2019
2	Thrombocytopenia (Thrombopenia) 04/2023 - 08/2022
2	Systemic Scleroderma (Systemic Sclerosis) 03/2023 - 06/2010
2	Necrosis 01/2023 - 07/2021
2	Arthralgia (Joint Pain) 01/2023 - 01/2021
2	Oral Ulcer (Mouth Ulcer) 10/2022 - 07/2021
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2021
2	Disease Progression 01/2022 - 02/2003
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 09/2020
2	Rheumatic Diseases (Rheumatism) 01/2021 - 01/2005
2	Dermatomyositis (Dermatopolymyositis) 01/2021 - 09/2020
2	Ankylosing Spondylitis 05/2019 - 02/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2019 - 02/2013
2	Lung Neoplasms (Lung Cancer) 01/2019 - 02/2003
2	Carcinogenesis 03/2016 - 07/2015
2	Prostatic Neoplasms (Prostate Cancer) 03/2016 - 07/2015
2	MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers) 05/2005 - 04/2005
1	Communicable Diseases (Infectious Diseases) 03/2024
1	Peritonitis 01/2024
1	Giant Cell Arteritis (Horton Disease) 01/2024
1	Macrocytic Anemia 10/2023
1	Skin Diseases (Skin Disease) 07/2023
1	Neutropenia 04/2023
1	Immune Reconstitution Inflammatory Syndrome 03/2023
1	Paresis (Hemiparesis) 03/2023
1	Iliac Aneurysm 01/2023
1	Antisynthetase syndrome 01/2023
1	Erythema Nodosum 10/2022
1	Oral Manifestations 10/2022
1	Skin Ulcer 10/2022

Drug/Important Bio-Agent (IBA)

12	EnzymesIBA 02/2024 - 04/2006
11	Transfer RNA (tRNA)IBA 01/2023 - 10/2004
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 03/2009
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2015
6	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 03/2009
5	Leu Transfer RNAIBA 03/2006 - 10/2004
5	Taurine FDA Link 05/2005 - 01/2003
4	GlucocorticoidsIBA 07/2023 - 01/2021
4	Heme (Haem)IBA 10/2018 - 01/2005
4	Heme Oxygenase-1IBA 09/2018 - 04/2006
4	AnticodonIBA 05/2005 - 10/2004
3	UbiquitinIBA 02/2024 - 01/2021
3	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2021
3	AntigensIBA 03/2023 - 03/2009
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 01/2021
3	tocilizumab (atlizumab)FDA Link 09/2022 - 11/2021
3	Ferritins (Ferritin)IBA 07/2021 - 01/2005
3	Interleukin-10 (Interleukin 10)IBA 12/2018 - 02/2013
3	Codon (Codons)IBA 03/2006 - 10/2004
3	UridineIBA 05/2005 - 01/2003
2	Infliximab (Remicade)FDA Link 06/2023 - 02/2007
2	ORALIT (ORS)IBA 04/2023 - 01/2023
2	LigandsIBA 04/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2015
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 01/2021
2	AutoantibodiesIBA 01/2023 - 01/2021
2	AntibodiesIBA 01/2023 - 01/2021
2	apremilastIBA 10/2022 - 07/2021
2	Monoclonal AntibodiesIBA 09/2022 - 02/2007
2	InterferonsIBA 08/2022 - 11/2018
2	AutoantigensIBA 11/2021 - 01/2020
2	Interferon Type IIBA 11/2021 - 10/2018
2	HLA-B Antigens (HLA-B)IBA 12/2018 - 06/2014
2	Glucose (Dextrose)FDA LinkGeneric 08/2017 - 01/2009
2	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2016 - 07/2015
2	Hormones (Hormone)IBA 03/2016 - 07/2015
2	5-taurinomethyluridineIBA 07/2008 - 05/2005
2	Lys Transfer RNAIBA 05/2005 - 04/2005
1	Small Untranslated RNAIBA 03/2024
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	Interleukin-6 InhibitorsIBA 12/2023
1	Interleukin-1 (Interleukin 1)IBA 12/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2023
1	Alkaline PhosphataseIBA 01/2023
1	SteroidsIBA 10/2022

Therapy/Procedure

5	Therapeutics 07/2023 - 02/2003
1	Peritoneal Dialysis 01/2024
1	Stem Cell Transplantation 03/2023
1	Endovascular Aneurysm Repair 01/2023